These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17059471)

  • 41. Factor Va, bound to microparticles released during platelet storage, is resistant to inactivation by activated protein C.
    Magdeleyns EJ; Keuren JF; Curvers J
    Transfusion; 2007 Oct; 47(10):1880-8. PubMed ID: 17880615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va.
    Van Walderveen MC; Berry LR; Atkinson HM; Chan AK
    Thromb Haemost; 2010 May; 103(5):910-9. PubMed ID: 20216984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma factor V activation is prevented by activated protein C in the presence of phospholipid vesicles, not platelets.
    Solymoss S; Nguyen KT
    Thromb Haemost; 1993 Feb; 69(2):124-9. PubMed ID: 8456424
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factor Va residues 311-325 represent an activated protein C binding region.
    Yegneswaran S; Kojima Y; Nguyen PM; Gale AJ; Heeb MJ; Griffin JH
    J Biol Chem; 2007 Sep; 282(39):28353-28361. PubMed ID: 17646160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative response of platelet fV and plasma fV to activated protein C and relevance to a model of acute traumatic coagulopathy.
    Campbell JE; Meledeo MA; Cap AP
    PLoS One; 2014; 9(6):e99181. PubMed ID: 24921658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of thrombin formation by active site mutated (S360A) activated protein C.
    Nicolaes GA; Bock PE; Segers K; Wildhagen KC; Dahlbäck B; Rosing J
    J Biol Chem; 2010 Jul; 285(30):22890-900. PubMed ID: 20484050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activated protein C inhibitor for correction of thrombin generation in hemophilia A blood and plasma1.
    Brummel-Ziedins KE; Whelihan MF; Rivard GE; Butenas S
    J Thromb Haemost; 2011 Nov; 9(11):2262-7. PubMed ID: 21920012
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered inactivation pathway of factor Va by activated protein C in the presence of heparin.
    Nicolaes GA; Sørensen KW; Friedrich U; Tans G; Rosing J; Autin L; Dahlbäck B; Villoutreix BO
    Eur J Biochem; 2004 Jul; 271(13):2724-36. PubMed ID: 15206937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Zymogen-like factor Xa variants restore thrombin generation and effectively bypass the intrinsic pathway in vitro.
    Bunce MW; Toso R; Camire RM
    Blood; 2011 Jan; 117(1):290-8. PubMed ID: 20864578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factor Xa activation of factor V is of paramount importance in initiating the coagulation system: lessons from a tick salivary protein.
    Schuijt TJ; Bakhtiari K; Daffre S; Deponte K; Wielders SJ; Marquart JA; Hovius JW; van der Poll T; Fikrig E; Bunce MW; Camire RM; Nicolaes GA; Meijers JC; van 't Veer C
    Circulation; 2013 Jul; 128(3):254-66. PubMed ID: 23817575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of thrombin formation by activated protein C: effect of the factor V Leiden mutation.
    Tans G; Nicolaes GA; Rosing J
    Semin Hematol; 1997 Jul; 34(3):244-55. PubMed ID: 9241709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.
    Egan JO; Kalafatis M; Mann KG
    Protein Sci; 1997 Sep; 6(9):2016-27. PubMed ID: 9300501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Down regulation of prothrombinase by activated protein C during prothrombin activation.
    Kim PY; Nesheim ME
    Thromb Haemost; 2010 Jul; 104(1):61-70. PubMed ID: 20390226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel APC-cleavage sites in FVa provide insights into mechanisms of action of APC and its cofactor protein S.
    Tran S; Dahlbäck B
    J Thromb Haemost; 2010 Jan; 8(1):129-36. PubMed ID: 19874463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.
    Heeb MJ; Mesters RM; Fernández JA; Hackeng TM; Nakasone RK; Griffin JH
    Thromb Haemost; 2013 Aug; 110(2):275-82. PubMed ID: 23892573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coinheritance of Factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G>A (FVII Lazio) mutation.
    Castoldi E; Govers-Riemslag JW; Pinotti M; Bindini D; Tans G; Berrettini M; Mazzucconi MG; Bernardi F; Rosing J
    Blood; 2003 Dec; 102(12):4014-20. PubMed ID: 12881304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factor Va-factor Xa interactions: molecular sites involved in enzyme:cofactor assembly.
    Steen M
    Scand J Clin Lab Invest Suppl; 2002; 237():5-11. PubMed ID: 12570161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex.
    Yegneswaran S; Banerjee Y; Fernández JA; Deguchi H; Griffin JH
    PLoS One; 2015; 10(8):e0135025. PubMed ID: 26263376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C.
    Camire RM; Kalafatis M; Simioni P; Girolami A; Tracy PB
    Blood; 1998 Apr; 91(8):2818-29. PubMed ID: 9531592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activated protein C resistance: molecular mechanisms.
    Griffin JH; Heeb MJ; Kojima Y; Fernández JA; Kojima K; Hackeng TM; Greengard JS
    Thromb Haemost; 1995 Jul; 74(1):444-8. PubMed ID: 8578503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.